Rajesh Chavan

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (6)

• Investigations on In Vivo Pharmacokinetic/Pharmacodynamic Determinants of Fosfomycin in Murine Thigh and Kidney Infection Models
  Microbial Drug Resistance 2023 DOI: 10.1089/mdr.2022.0119
  +Save
• In-vitro antibacterial activity of Fosfomycin and Nitrofurantoin against Pseudomonas aeruginosa and Acinetobacter baumannii against clinical isolates collected from Indian tertiary care hospitals
  Journal of Drug Delivery and Therapeutics 2022 DOI: 10.22270/jddt.v12i3-S.5356
  +Save
• Preclinical safety evaluation of nafithromycin (WCK 4873) with emphasis on liver safety in rat and dog
  Regulatory Toxicology and Pharmacology 2021 DOI: 10.1016/j.yrtph.2021.104889
  +Save
• Assessment of the in vitro cytochrome P450 (CYP) inhibition potential of nafithromycin, a next generation lactone ketolide antibiotic
  Xenobiotica 2021 DOI: 10.1080/00498254.2020.1839983
  +Save
• Assessment of in vitro inhibitory effects of novel anti MRSA benzoquinolizine fluoroquinolone WCK 771 (levonadifloxacin) and its metabolite on human liver cytochrome P450 enzymes
  Xenobiotica 2020 DOI: 10.1080/00498254.2020.1756007
  +Save
• <p>Levonadifloxacin, a Novel Broad-Spectrum Anti-MRSA Benzoquinolizine Quinolone Agent: Review of Current Evidence</p>
  Drug Design, Development and Therapy 2019 DOI: 10.2147/DDDT.S229882
  +Save